Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan and Amlodipine vs Amlodipine in Primary Hypertension
CTR20222998Phase 3Completed
- Sponsor
- Hunan Huize Biopharmaceutical Technology
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + amlodipine in essential hypertension, sponsored by Hunan Huize Biopharmaceutical Technology. Started Jan 2023; status: completed.
02
Drugs
irbesartan + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20222998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222998.